ARL vs VRTX · P/E 20, rev $12.9M vs P/E 30, rev $3.33B
American Realty Investors Inc (ARL) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
American Realty Investors Inc (ARL) is a real estate services company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ARL revenue for 2026-06-30 was $12.9M. Net income was -$1.0M. Revenue was up 4.3% from 2026-03-31 to 2026-06-30. ARL currently screens at market cap $242.3M and trailing P/E 19.7.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ARL currently screens at market cap $242.3M and trailing P/E 19.7. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ARL and VRTX stock pages for the full models.
Not investment advice.